지루피부염의 약물치료 = Pharmacologic treatment of seborrheic dermatitis

다국어 초록 (Multilingual Abstract)

Seborrheic dermatitis is a chronic, recurrent papulosquamous skin disorder characterized by flaking of the skin, erythema, pruritus, and oily skin. It is a common dermatosis, with a prevalence of approximately 1% to 3% of the general population in the United States. The incidence of this skin disease has a bimodal distribution, with peaks noted in newborns and in adults between 30 and 60 years of age. In adults, it predominantly occurs over areas of the body with a high concentration of sebaceous glands. The etiology of this disease is thought to be an inflammatory response of the body to Malassezia yeasts. It is also related to abnormal sebum secretion, as well as a heightened immune response of the host. Based on the characteristic features of this inflammatory skin disease, the mainstays of treatment for seborrheic dermatitis are antifungals, corticosteroids, and immunomodulatory agents. The primary goal of therapy for seborrheic dermatitis is to manage acute symptoms, including pruritus, erythema, and scaling. Maintenance treatment is directed toward preventing the recurrence of acute exacerbations. Patients should be informed that seborrheic dermatitis is a chronic condition, with a tendency to recur despite proper treatment. Clinicians should offer suggestions about lifestyle modifications to avoid triggers and choose proper treatment options that ensure the patient’s safety.

참고문헌 (Reference)

1 Geissler SE, "Very low dose isotretinoin is effective in controlling seborrhea" 1 : 952-958, 2003

2 Satchell AC, "Treatment of dandruff with 5% tea tree oil shampoo" 47 : 852-855, 2002

3 Fabbrocini G, "Topical nicotinamide for seborrheic dermatitis: an open randomized study" 25 : 241-245, 2014

4 Kastarinen H, "Topical antiinflammatory agents for seborrheic dermatitis of the face or scalp: summary of a Cochrane Review" 151 : 221-222, 2015

5 Berger TG, "The use of topical calcineurin inhibitors in dermatology:safety concerns: report of the American Academy of Dermatology Association Task Force" 54 : 818-823, 2006

6 Van Cutsem J, "The antiinflammatory effects of ketoconazole: a comparative study with hydrocortisone acetate in a model using living and killed Staphylococcus aureus on the skin of guinea-pigs" 25 (25): 257-261, 1991

7 Nenoff P, "The antifungal activity of a coal tar gel on Malassezia furfur in vitro" 191 : 311-314, 1995

8 Shuster S., "The aetiology of dandruff and the mode of action of therapeutic agents" 111 : 235-242, 1984

9 Lee JH, "Successful treatment of dandruff with 1.5% ciclopirox olamine shampoo in Korea" 14 : 212-215, 2003

10 Goldust M, "Sertaconazole 2% cream versus hydrocortisone 1% cream in the treatment of seborrheic dermatitis" 2013

11 Schwartz RA, "Seborrheic dermatitis:an overview" 74 : 125-130, 2006

12 Gupta AK, "Role of antifungal agents in the treatment of seborrheic dermatitis" 5 : 417-422, 2004

13 Dupuy P, "Randomized, placebo-controlled, double-blind study on clinical efficacy of ciclopiroxolamine 1% cream in facial seborrhoeic dermatitis" 144 : 1033-1037, 2001

14 Lee YW, "Quantitative investigation on the distribution of Malassezia species on healthy human skin in Korea" 49 : 405-410, 2006

15 Homeyer DC, "In vitro activity of Melaleuca alternifolia (tea tree) oil on filamentous fungi and toxicity to human cells" 53 : 285-294, 2015

16 Pierard-Franchimont C, "From axioms to new insights into dandruff" 200 : 93-98, 2000

17 Scaparro E, "Evaluation of the efficacy and tolerability of oral terbinafine (Daskil)in patients with seborrhoeic dermatitis: a multicentre, randomized, investigator-blinded, placebo-controlled trial" 144 : 854-857, 2001

18 Altmeyer P, "Efficacy of different concentrations of ciclopirox shampoo for the treatment of seborrheic dermatitis of the scalp: results of a randomized, double-blind, vehiclecontrolled trial" 43 (43): 9-12, 2004

19 Elewski B, "Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a phase III trial" 5 : 646-650, 2006

20 Schlesinger T, "Efficacy and safety of a low molecular weight hyaluronic Acid topical gel in the treatment of facial seborrheic dermatitis final report" 7 : 15-18, 2014

21 윤혜정, "Efficacy and Safety of Cream Containing Climbazole/Piroctone Olamine for Facial Seborrheic Dermatitis: A Single-Center, Open-Label Split-Face Clinical Study" 대한피부과학회 28 (28): 733-739, 2016

22 Ortonne JP, "Efficacious and safe management of moderate to severe scalp seborrhoeic dermatitis using clobetasol propionate shampoo 0·05% combined with ketoconazole shampoo 2%: a randomized, controlled study" 165 : 171-176, 2011

23 Mayer-da-Silva A, "Effects of azelaic acid on sebaceous gland, sebum excretion rate and keratinization pattern in human skin: an in vivo and in vitro study" 143 : 20-30, 1989

24 Nicolas V, "Effects of acidic fibroblast growth factor and epidermal growth factor on subconfluent fetal rat calvaria cell cultures: DNA synthesis and alkaline phosphatase activity" 8 : 145-156, 1990

25 Mills KJ, "Dandruff/seborrhoeic dermatitis is characterized by an inflammatory genomic signature and possible immune dysfunction: transcriptional analysis of the condition and treatment effects of zinc pyrithione" 166 (166): 33-40, 2012

26 Warner RR, "Dandruff has an altered stratum corneum ultrastructure that is improved with zinc pyrithione shampoo" 45 : 897-903, 2001

27 Lassus A, "Comparison of ciclopirox olamine 1% cream with ciclopirox 1%-hydrocortisone acetate 1% cream in the treatment of inflamed superficial mycoses" 10 : 594-599, 1988

28 Poulin Y, "Clobetasol propionate shampoo 0.05% is efficacious and safe for longterm control of scalp psoriasis" 85 : 43-50, 2010

29 Reygagne P, "Clobetasol propionate shampoo 0.05% in the treatment of seborrheic dermatitis of the scalp: results of a pilot study" 79 : 397-403, 2007

30 Peyri J, "Clinical and therapeutic profile and quality of life of patients with seborrheic dermatitis" 98 : 476-482, 2007

31 김유리, "Clinical Evaluation of a New-Formula Shampoo for Scalp Seborrheic Dermatitis Containing Extract of Rosa centifolia Petals and Epigallocatechin Gallate: A Randomized, Double-Blind, Controlled Study" 대한피부과학회 26 (26): 733-738, 2014

32 Nenoff P, "Antifungal activity of the essential oil of Melaleuca alternifolia (tea tree oil) against pathogenic fungi in vitro" 9 : 388-394, 1996

33 Faergemann J, "An immunologic and cultural study of Pityrosporum folliculitis" 14 : 429-433, 1986

34 Pazyar N, "A review of applications of tea tree oil in dermatology" 52 : 784-790, 2013

35 Danby FW, "A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff" 29 : 1008-1012, 1993

36 Rapaport M., "A randomized, controlled clinical trial of four anti-dandruff shampoos" 9 : 152-156, 1981

37 Squire RA, "A randomised, single-blind, singlecentre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff/seborrhoeic dermatitis" 13 : 51-60, 2002

38 Kwon SH, "A new therapeutic option for facial seborrhoeic dermatitis:indole-3-acetic acid photodynamic therapy" 28 : 94-, 2014

39 Katsambas A, "A double-blind trial of treatment of seborrhoeic dermatitis with 2% ketoconazole cream compared with 1% hydrocortisone cream" 121 : 353-357, 1989

40 Schwartz JR, "A comprehensive pathophysiology of dandruff and seborrheic dermatitis: towards a more precise definition of scalp health" 93 : 131-137, 2013